About: Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.49 (+0.53%)
PHAR NASDAQ Pharming Group NV
Pharming Group NV share price
PHAR price activity
Last Price
$9.490
Change (24hr)
0.05 USD (0.53%)
Volume
1.10K
Volume (4w avg)
-
Open
$9.55
Day Range
$9.49 - $9.55
Previous Close
$9.44
Last Trade
14 Oct, 5:02 pm GMT+0
Delayed
14 Oct, 5:02 pm GMT+0
PHAR price performance
Delayed
14 Oct, 5:02 pm GMT+0
PHAR Market Signals